Shenzhen Rivaroxaban Co.,Ltd
Home
About us
Products
Rivaroxaban
Pharmaceutical Intermediates
Tegprazan
VeMurafenib
Anti-diabetic
Antiviral Drug
Antidepressants
Anti-cancer Drugs
High Polymer Materials
Complementary Medicines
Cardiovascular Medications
News
Blog
Contact us
Language
English
Français
Deutsch
Español
Italiano
Português
日本語
한국어
Русский
Home
>
Blog
>
CMS names 10 drugs up for first price negotiations under IRA
LATEST NEWS
IRA’s Drug Price Negotiation Program Could Save Medicare $1.8B in First Year
WILLOW ANNOUNCES COLLABORATION WITH A LEADING INNOVATIVE BIOPHARMACEUTICAL COMPANY TO DEVELOP SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTS
Vemurafenib by F. Hoffmann
FRAIL
GlucoTrust Reviews
CMS names 10 drugs up for first price negotiations under IRA
Feb 13, 2024
previous:
Traditional medicine can improve people
Aspirin can help reduce risk of second heart attack, study finds, but less than half of eligible adults take it
:next
Name:
*
E-mail:
*
Phone/WhatsApp:
*
Subject:
*
Content:
*
Send to us